摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,4R)-3,4-bis(tert-butyldimethylsilyloxy)-1-methylpyrrolidine-2,5-dione | 133710-11-9

中文名称
——
中文别名
——
英文名称
(3R,4R)-3,4-bis(tert-butyldimethylsilyloxy)-1-methylpyrrolidine-2,5-dione
英文别名
(3R,4R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-1-methylpyrrolidine-2,5-dione
(3R,4R)-3,4-bis(tert-butyldimethylsilyloxy)-1-methylpyrrolidine-2,5-dione化学式
CAS
133710-11-9
化学式
C17H35NO4Si2
mdl
——
分子量
373.64
InChiKey
XZOPQYQTPYVDGC-CHWSQXEVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.77
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3R,4R)-3,4-bis(tert-butyldimethylsilyloxy)-1-methylpyrrolidine-2,5-dione三乙基硅烷三氟化硼乙醚 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 生成 (3R,4S,5S)-5-Benzyl-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-1-methyl-pyrrolidin-2-one
    参考文献:
    名称:
    使用具有C 2对称性的环状酰亚胺的手性烷基化内酰胺的新型合成策略
    摘要:
    在路易斯酸存在下,用Et 3 SiH容易地由C 2对称酰亚胺的烷基化反应制得的季铵α-羟基内酰胺的还原脱氧显示出极高的立体选择性以提供相应的内酰胺。通过空前的反式反应,通过转化成已知的内酰胺,已明确确认生成的新的立体异构中心的立体化学是S。
    DOI:
    10.1016/s0957-4166(00)80339-0
  • 作为产物:
    描述:
    (3R,4R)-3,4-diacetoxy-1-methylpyrrolidine-2,5-dione 在 咪唑乙酰氯 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 生成 (3R,4R)-3,4-bis(tert-butyldimethylsilyloxy)-1-methylpyrrolidine-2,5-dione
    参考文献:
    名称:
    Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors
    摘要:
    Human immunodeficiency virus (HIV) integrase (IN) catalyzes the integration of HIV DNA copy into the host cell DNA. Such integration is essential for the production of progeny viruses, and therefore therapeutic agents that can inhibit this process should be effective anti-HIV agents. We have previously reported the inhibitory activity of dicaffeoylglucosides against HIV IN. In the present study, we have synthesized and tested dicaffeoyl or digalloyl compounds joined through a five-membered heterocyclic ring as HIV IN inhibitors to explore the SARs of this family of compounds. The starting heterocyclic diols were prepared from L-tartaric acid, diethyl L-tartarate or D-(+)-ribonic gamma -lactone. We found that the HIV IN inhibitory activities of dicaffeoyl derivatives were comparable to that of L-chicoric acid (IC50 = 24.9 muM). On the other hand, digalloyl derivatives were more potent than L-chicoric acid with IC50 Values of 4.7-15.6 muM. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00013-x
点击查看最新优质反应信息

文献信息

  • Chiral cyclic imides with c2-symmetry. Novel reagents for the synthesis of optically pure lactones containing three contiguous tertiary centers
    作者:Hidemi Yoda、Koji Shirakawa、Kunihiko Takabe
    DOI:10.1016/s0040-4039(00)92719-9
    日期:1991.7
    Asymmetric reactions employing C2-symmetrical imides readily prepared from L-tartaric acid with Grignard reagents and sodium borohydride afforded a separable mixture of two hydroxyamides with high diastereoselectivity. Products were lactonized respectively to provide optically pure γ- alkylated lactones with contiguous tertiary carbon centers. The reaction mechanisms in asymmetric induction were also
    使用由L-酒石酸与Grignard试剂和氢硼化钠轻松制备的C 2-对称酰亚胺进行的不对称反应提供了具有高非对映选择性的两种羟酰胺的可分离混合物。将产物分别内酯化以提供具有连续的叔碳中心的光学纯的γ-烷基化内酯。还讨论了不对称诱导中的反应机理。
  • Diastereomer differentiation during 1,2-addition of Grignard reagents under rotamer distribution control
    作者:Hidemi Yoda、Hidekazu Kitayama、Kunihiko Takabe、Akikazu Kakehi
    DOI:10.1016/s0957-4166(00)80410-3
    日期:1993.8
    Construction of (R)-tertiary alcohols through diastereofacial differentiation under rotamer distribution control was accomplished with complete selectivity by means of simple nucleophilic addition of Grignard reagents to chiral α-ketoamides elaborated from C2-symmetrical imides and the absolute configuration was established by an X-ray crystallographic analysis.
    在旋转异构体分布控制下,通过非对面分化构建(R)叔醇,是通过将格氏试剂简单亲核加到C 2对称酰亚胺制得的手性α-酮酰胺上而完全选择性地完成的,并且绝对构型由X确定射线晶体学分析。
  • Yoda, Hidemi; Shirakawa, Koji; Takabe, Kunihiko, Chemistry Letters, 1991, # 3, p. 489 - 490
    作者:Yoda, Hidemi、Shirakawa, Koji、Takabe, Kunihiko
    DOI:——
    日期:——
  • YODA, HIDEMI;SHIRAKAWA, KOJI;TAKABE, KUNIHIKO, CHEM. LETT.,(1991) N, C. 489-490
    作者:YODA, HIDEMI、SHIRAKAWA, KOJI、TAKABE, KUNIHIKO
    DOI:——
    日期:——
  • Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors
    作者:Dong Jin Hwang、Sun Nam Kim、Jung Hoon Choi、Yong Sup Lee
    DOI:10.1016/s0968-0896(01)00013-x
    日期:2001.6
    Human immunodeficiency virus (HIV) integrase (IN) catalyzes the integration of HIV DNA copy into the host cell DNA. Such integration is essential for the production of progeny viruses, and therefore therapeutic agents that can inhibit this process should be effective anti-HIV agents. We have previously reported the inhibitory activity of dicaffeoylglucosides against HIV IN. In the present study, we have synthesized and tested dicaffeoyl or digalloyl compounds joined through a five-membered heterocyclic ring as HIV IN inhibitors to explore the SARs of this family of compounds. The starting heterocyclic diols were prepared from L-tartaric acid, diethyl L-tartarate or D-(+)-ribonic gamma -lactone. We found that the HIV IN inhibitory activities of dicaffeoyl derivatives were comparable to that of L-chicoric acid (IC50 = 24.9 muM). On the other hand, digalloyl derivatives were more potent than L-chicoric acid with IC50 Values of 4.7-15.6 muM. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物